2011•Laboratory Medicine and ClinicRequires access

Clinical significance of detection on serum levels of β_2-microglobulin and C-reactive protein in patients with multiple myeloma

Hongying Jiang

Open publisher page 0 citations

Abstract

Objective To investigate the changes of the serum levels of β2-microglobulin(β2-MG) and C-reactive protein in patients with multiple myeloma(MM) and their clinical implications.Methods The latex-enhanced immunity transmission turbidity method was applied to measure the serum levels of β2-MG and CRP between 60 MM patients and 40 healthy controls and a comparative analysis was performed concerning the alterations in serum varying β2-MG and CRP levels of the varying clinical stages before and after treatment.Results The serum levels of β2-MG and CRP were higher of the MM group than that of the control group,and they increased significantly with the increase of clinical stage,the result was significant different(P0.01).The serum levels of β2-MG and CRP in MM group with effective treatment decreased after treatment compared with those before treatment,the result was significantly different(P0.01),while the result in MM group with effectiveless treatment before and after treatment was not significantly different(P0.05).Conclusion Measurement of serum β2-MG and CRP may be used as an indicator to evaluate the therapeutic effect and prognosis of MM.

About this research paper

What this paper is about

Objective To investigate the changes of the serum levels of β2-microglobulin(β2-MG) and C-reactive protein in patients with multiple myeloma(MM) and their clinical implications.Methods The latex-enhanced immunity transmission turbidity method was applied to measure the serum levels of β2-MG and CRP between 60 MM patients and 40 healthy controls and a comparative analysis was performed concerning the alterations in serum varying β2-MG and CRP levels of the varying clinical stages before and after treatment.Results The serum levels of β2-MG and CRP were higher of the MM group than that of the control group,and they increased significantly with the increase of clinical stage,the result was significant different(P0.01).The serum levels of β2-MG and CRP in MM group with effective treatment decreased after treatment compared with those before treatment,the result was significantly different(P0.01),while the result in MM group with effectiveless treatment before and after treatment was not significantly different(P0.05).Conclusion Measurement of serum β2-MG and CRP may be used as an indicator to evaluate the therapeutic effect and prognosis of MM.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the changes of the serum levels of β2-microglobulin(β2-MG) and C-reactive protein in patients with multiple myeloma(MM) and their clinical implications.Methods The latex-enhanced immunity transmission turbidity method was applied to measure the serum levels of β2-MG and CRP between 60 MM patients and 40 healthy controls and a comparative analysis was performed concerning the alterations in serum varying β2-MG and CRP levels of the varying clinical stages before and after treatment.Results The serum levels of β2-MG and CRP were higher of the MM group than that of the control group,and they increased significantly with the increase of clinical stage,the result was significant different(P0.01).The serum levels of β2-MG and CRP in MM group with effective treatment decreased after treatment compared with those before treatment,the result was significantly different(P0.01),while the result in MM group with effectiveless treatment before and after treatment was not significantly different(P0.05).Conclusion Measurement of serum β2-MG and CRP may be used as an indicator to evaluate the therapeutic effect and prognosis of MM.

Key concepts: Beta-2 microglobulin, Multiple myeloma, C-reactive protein, Gastroenterology, Internal medicine, Medicine, Stage (stratigraphy), Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical significance of detection on serum levels of β_2-microglobulin and C-reactive protein in patients with multiple myeloma — Research Paper | ScholarLens